BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6138470)

  • 1. The beta-adrenergic blockade withdrawal phenomenon.
    Walden RJ; Tomlinson B; Bhattacharjee P; Prichard BN
    J Pharmacol; 1983; 14 Suppl 2():35-48. PubMed ID: 6138470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beta-adrenergic blockade withdrawal phenomenon.
    Prichard BN; Tomlinson B; Walden RJ; Bhattacharjee P
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S56-62. PubMed ID: 6188921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withdrawal of beta-blocking drugs.
    Walden RJ; Hernandez J; Yu Y; Al-Khader A; Prichard BN
    Am Heart J; 1982 Aug; 104(2 Pt 2):515-20. PubMed ID: 6125098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Withdrawal of preparations blocking beta-adrenergic receptors].
    Prichard BN; Bhattacharjee P; Tomlinson B; Walden RJ
    Ter Arkh; 1982; 54(11):38-45. PubMed ID: 6130620
    [No Abstract]   [Full Text] [Related]  

  • 5. [Beta-blocker withdrawal syndrome].
    Goliakov VN; Zimin IuV
    Klin Med (Mosk); 1984 Mar; 62(3):15-22. PubMed ID: 6143853
    [No Abstract]   [Full Text] [Related]  

  • 6. The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs.
    Prichard BN; Walden RJ
    Br J Clin Pharmacol; 1982; 13(Suppl 2):337S-343S. PubMed ID: 6125186
    [No Abstract]   [Full Text] [Related]  

  • 7. [Symptoms and cardiovascular complications of the withdrawal of beta-blocker treatment. Practical implications].
    Plouin PF
    Therapie; 1984; 39(4):379-90. PubMed ID: 6148791
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of intrinsic sympathomimetic activity on beta-receptor responsiveness after beta-adrenoceptor blockade withdrawal.
    Walden RJ; Bhattacharjee P; Tomlinson B; Cashin J; Graham BR; Prichard BN
    Br J Clin Pharmacol; 1982; 13(Suppl 2):359S-364S. PubMed ID: 6125188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beta-adrenergic system in man: physiological and pathophysiological response. Regulation of receptor density and functioning.
    Mäki T; Kontula K; Härkönen M
    Scand J Clin Lab Invest Suppl; 1990; 201():25-43. PubMed ID: 1978755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Withdrawal phenomena after chronic beta-blockade. Causes and therapeutic consequences].
    Krämer B; Kübler W
    Dtsch Med Wochenschr; 1984 Mar; 109(12):465-71. PubMed ID: 6142815
    [No Abstract]   [Full Text] [Related]  

  • 11. Myocardial sensitivity to isoproterenol following abrupt propranolol withdrawal in conscious dogs.
    Webb JG; Newman WH; Walle T; Daniell HB
    J Cardiovasc Pharmacol; 1981; 3(3):622-35. PubMed ID: 6168842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained cardiac beta adrenoceptor blockade in vitro and increased vulnerability to aconitine-induced arrhythmias in vivo after propranolol withdrawal in rats.
    Hedberg A; Isaksson O; Lundgren B
    J Pharmacol Exp Ther; 1980 Sep; 214(3):664-9. PubMed ID: 6249914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of heart failure with beta-blockers?].
    Osterziel KJ; Dietz R
    Z Kardiol; 1997 Jan; 86(1):1-8. PubMed ID: 9133118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risks in sudden withdrawal of beta-blocking drugs--beta-blockade withdrawal syndrome].
    Kristensen BO
    Ugeskr Laeger; 1978 Sep; 140(39):2357-60. PubMed ID: 29369
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta blocker withdrawal: the role of the beta adrenoceptor.
    Maling TJ
    N Z Med J; 1984 Feb; 97(749):76-7. PubMed ID: 6142439
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
    Kampman KM; Dackis C; Lynch KG; Pettinati H; Tirado C; Gariti P; Sparkman T; Atzram M; O'Brien CP
    Drug Alcohol Depend; 2006 Nov; 85(2):129-37. PubMed ID: 16697124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug information. Beta receptor blocking drugs in the treatment of hypertension. A review].
    Jensen HA; Rasmussen K
    Ugeskr Laeger; 1976 Nov; 138(47):2965-9. PubMed ID: 10660
    [No Abstract]   [Full Text] [Related]  

  • 18. Withdrawal syndromes and the cessation of antihypertensive therapy.
    Hart GR; Anderson RJ
    Arch Intern Med; 1981 Aug; 141(9):1125-7. PubMed ID: 6114720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol.
    Rangno RE; Langlois S
    Br J Clin Pharmacol; 1982; 13(Suppl 2):345S-351S. PubMed ID: 6125187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autonomic antecedents to variant angina exacerbation after beta-blockade withdrawal.
    Chiladakis JA; Alexopoulos D
    J Electrocardiol; 2005 Jan; 38(1):82-4. PubMed ID: 15660353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.